Mankind Pharma
BSE: 543904 | NSE: MANKIND | ISIN: INE634S01028 | SECTOR:Open
1,767.00High
1,845.05Low
1,763.00Prev Close
1,764.60P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
718.32BVolume
48.81KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
1,793.15
Company Description
BSE
543904NSE
MANKINDISIN
INE634S01028
Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.
Company Officers
Ramesh Juneja
Executive Chairman of the BoardSheetal Arora
Chief Executive Officer, Whole-Time DirectorRajeev Juneja
Executive Vice Chairman of the Board, Managing DirectorAshutosh Dhawan
Chief Financial OfficerArjun Juneja
Chief Operating OfficerPradeep Chugh
Compliance Officer, Company SecretarySatish Sharma
Whole-Time Director